Birmingham epidermolysis severity score and vitamin D status are associated with low BMD in children with epidermolysis bullosa
- 23 December 2016
- journal article
- research article
- Published by Springer Nature in Osteoporosis International
- Vol. 28 (4) , 1385-1392
Abstract
Summary Bone status impairment represents a complication of generalized forms of epidermolysis bullosa (EB); however, the prevalence and the main determinants of this event in localized forms remain poorly defined. Birmingham epidermolysis bullosa severity (BEBS) score and 25-hydroxyvitamin D levels are strongly associated with low bone mass, suggesting that vitamin D may play a potential beneficial role in bone health. Further longitudinal studies are needed in order to confirm this hypothesis. Introduction Bone status impairment represents a complication of generalized forms of EB; thus, we aimed to estimate the prevalence of low bone mass, to examine mineralization differences in various EB subtypes and to identify the most important determinants of bone impairment in children with either generalized or localized EB. Methods An observational study of 20 children (11 males; mean age ± standard deviation, 11.7 ± 3.9 years) with EB was performed. Clinical history, physical examination, laboratory studies, X-ray of the left hand and wrist for bone age, and dual energy X-ray absorptiometry scans of the lumbar spine were obtained. Areal bone mineral density (aBMD Z-scores) and bone mineral apparent density were related to the BEBS score. Results Areal BMD Z-score (mean −1.82 ± 2.33, range, −7.6-1.7) was reduced (<−2 SD) in 8 patients (40%), whereas aBMD Z-score adjusted for bone age was low in 7 patients (35%). BEBS score and 25-hydroxyvitamin D serum levels were the most important elements associated with aBMD (P = 0.0001 and P = 0.016, respectively). A significant correlation between the aBMD Z-score and area of skin damage, insulin-like growth factor-1, C-reactive protein, and sodium serum levels was also found. Conclusions Low aBMD can be considered a systemic complication of EB, primarily associated with BEBS score and 25-hydroxyvitamin D levels. Therefore, longitudinal evaluation of bone status is ongoing in these patients to define whether vitamin D supplementation would prevent, or at least reduce, bone status impairment.Keywords
Funding Information
- by Ricerca Corrente Funds of Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico
This publication has 30 references indexed in Scilit:
- Proinflammatory Cytokines and Antiskin Autoantibodies in Patients With Inherited Epidermolysis BullosaMedicine, 2015
- Vitamin D and skeletal health in autoimmune bullous skin diseases: a case control studyOrphanet Journal of Rare Diseases, 2015
- Vitamin D status and predictors of hypovitaminosis D in Italian children and adolescents: a cross-sectional studyEuropean Journal of Pediatrics, 2013
- Guidelines for Preventing and Treating Vitamin D Deficiency and Insufficiency RevisitedThe Journal of Clinical Endocrinology & Metabolism, 2012
- Correlates of low bone mass in children with generalized forms of epidermolysis bullosaJournal of the American Academy of Dermatology, 2011
- Height Adjustment in Assessing Dual Energy X-Ray Absorptiometry Measurements of Bone Mass and Density in ChildrenThe Journal of Clinical Endocrinology & Metabolism, 2010
- Extracutaneous manifestations and complications of inherited epidermolysis bullosaJournal of the American Academy of Dermatology, 2009
- Osteoporosis in children and adolescentsBone, 2007
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- Acquisition of optimal bone mass in childhood and adolescenceTrends in Endocrinology & Metabolism, 2001